Page last updated: 2024-08-07 17:20:49
Nicastrin
A nicastrin that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q92542]
Synonyms
Research
Bioassay Publications (31)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (25.81) | 29.6817 |
2010's | 20 (64.52) | 24.3611 |
2020's | 3 (9.68) | 2.80 |
Compounds (21)
Drugs with Inhibition Measurements
Drugs with Activation Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
cholanic acid | Homo sapiens (human) | EC50 | 5.7000 | 1 | 1 |
t0901317 | Homo sapiens (human) | EC50 | 3.6000 | 1 | 1 |
ly 450139 | Homo sapiens (human) | EC50 | 0.0769 | 2 | 2 |
ly 411575 | Homo sapiens (human) | EC50 | 0.0001 | 1 | 1 |
begacestat | Homo sapiens (human) | EC50 | 0.0141 | 3 | 3 |
e 2012 | Homo sapiens (human) | EC50 | 0.0830 | 1 | 1 |
mrk 560 | Homo sapiens (human) | EC50 | 0.0006 | 1 | 1 |
ro 4929097 | Homo sapiens (human) | EC50 | 0.0095 | 2 | 2 |
Drugs with Other Measurements
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
SAR-studies of γ-secretase modulators with PPARγ-agonistic and 5-lipoxygenase-inhibitory activity for Alzheimer's disease.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 25, Issue:4, 2015
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacology.The Journal of biological chemistry, , Dec-21, Volume: 282, Issue:51, 2007
Novel Notch-sparing gamma-secretase inhibitors derived from a peroxisome proliferator-activated receptor agonist library.Bioorganic & medicinal chemistry letters, , Sep-01, Volume: 20, Issue:17, 2010
Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacology.The Journal of biological chemistry, , Dec-21, Volume: 282, Issue:51, 2007
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Development of clickable active site-directed photoaffinity probes for γ-secretase.Bioorganic & medicinal chemistry letters, , Apr-15, Volume: 22, Issue:8, 2012
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacology.The Journal of biological chemistry, , Dec-21, Volume: 282, Issue:51, 2007
Small molecules targeting γ-secretase and their potential biological applications.European journal of medicinal chemistry, , Mar-15, Volume: 232, 2022
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007Journal of medicinal chemistry, , Jul-11, Volume: 56, Issue:13, 2013
Piperidine-derived gamma-secretase modulators.Bioorganic & medicinal chemistry letters, , Feb-01, Volume: 20, Issue:3, 2010
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
Discovery of a novel series of Notch-sparing gamma-secretase inhibitors.Bioorganic & medicinal chemistry letters, , Jul-15, Volume: 18, Issue:14, 2008
Amide Bond Bioisosteres: Strategies, Synthesis, and Successes.Journal of medicinal chemistry, , 11-12, Volume: 63, Issue:21, 2020
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer's disease.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 23, Issue:23, 2013
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
Insensitivity to Abeta42-lowering nonsteroidal anti-inflammatory drugs and gamma-secretase inhibitors is common among aggressive presenilin-1 mutations.The Journal of biological chemistry, , Aug-24, Volume: 282, Issue:34, 2007
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
N-Substituted carbazolyloxyacetic acids modulate Alzheimer associated gamma-secretase.Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 17, Issue:1, 2007
Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacology.The Journal of biological chemistry, , Dec-21, Volume: 282, Issue:51, 2007
Small molecules targeting γ-secretase and their potential biological applications.European journal of medicinal chemistry, , Mar-15, Volume: 232, 2022
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007Journal of medicinal chemistry, , Jul-11, Volume: 56, Issue:13, 2013
Discovery of a novel [3.2.1] benzo fused bicyclic sulfonamide-pyrazoles as potent, selective and efficacious γ-secretase inhibitors.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 23, Issue:4, 2013
Effect of helical conformation and side chain structure on γ-secretase inhibition by β-peptide foldamers: insight into substrate recognition.Journal of medicinal chemistry, , Feb-28, Volume: 56, Issue:4, 2013
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.Journal of medicinal chemistry, , Dec-11, Volume: 51, Issue:23, 2008
Generation of Leads for γ-Secretase Modulation.Journal of medicinal chemistry, , 08-13, Volume: 63, Issue:15, 2020
Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead.European journal of medicinal chemistry, , Mar-25, Volume: 148, 2018
Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators.ACS medicinal chemistry letters, , Oct-12, Volume: 8, Issue:10, 2017
Gamma Secretase Modulators: New Alzheimer's Drugs on the Horizon?Journal of medicinal chemistry, , Aug-25, Volume: 59, Issue:16, 2016
Potent benzoazepinone γ-secretase modulators with improved bioavailability.Bioorganic & medicinal chemistry letters, , Sep-01, Volume: 25, Issue:17, 2015
Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer's disease.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 23, Issue:23, 2013
Design and synthesis of a novel series of bicyclic heterocycles as potent γ-secretase modulators.Journal of medicinal chemistry, , Nov-08, Volume: 55, Issue:21, 2012
Cyclic hydroxyamidines as amide isosteres: discovery of oxadiazolines and oxadiazines as potent and highly efficacious γ-secretase modulators in vivo.Journal of medicinal chemistry, , Jan-12, Volume: 55, Issue:1, 2012
Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 21, Issue:2, 2011
Iminoheterocycles as gamma-secretase modulators.Bioorganic & medicinal chemistry letters, , Sep-15, Volume: 20, Issue:18, 2010
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Discovery of a Novel, Potent Spirocyclic Series of γ-Secretase Inhibitors.Journal of medicinal chemistry, , Nov-25, Volume: 58, Issue:22, 2015
4-substituted cyclohexyl sulfones as potent, orally active gamma-secretase inhibitors.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 16, Issue:2, 2006
Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead.European journal of medicinal chemistry, , Mar-25, Volume: 148, 2018
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Design, synthesis, and in vivo characterization of a novel series of tetralin amino imidazoles as γ-secretase inhibitors: discovery of PF-3084014.Bioorganic & medicinal chemistry letters, , May-01, Volume: 21, Issue:9, 2011
Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead.European journal of medicinal chemistry, , Mar-25, Volume: 148, 2018
Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007Journal of medicinal chemistry, , Jul-11, Volume: 56, Issue:13, 2013
Discovery of a novel [3.2.1] benzo fused bicyclic sulfonamide-pyrazoles as potent, selective and efficacious γ-secretase inhibitors.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 23, Issue:4, 2013
Application of the bicyclo[1.1.1]pentane motif as a nonclassical phenyl ring bioisostere in the design of a potent and orally active γ-secretase inhibitor.Journal of medicinal chemistry, , Apr-12, Volume: 55, Issue:7, 2012
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007Journal of medicinal chemistry, , Jul-11, Volume: 56, Issue:13, 2013
Discovery of a novel [3.2.1] benzo fused bicyclic sulfonamide-pyrazoles as potent, selective and efficacious γ-secretase inhibitors.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 23, Issue:4, 2013
Enables
This protein enables 5 target(s):
Target | Category | Definition |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
protein-macromolecule adaptor activity | molecular function | The binding activity of a protein that brings together two or more macromolecules in contact, permitting those molecules to function in a coordinated way. The adaptor can bring together two proteins, or a protein and another macromolecule such as a lipid or a nucleic acid. [GOC:bf, GOC:mah, GOC:vw] |
aspartic endopeptidase activity, intramembrane cleaving | molecular function | Catalysis of the hydrolysis of nonterminal peptide bonds in a polypeptide chain, occurring within a membrane. [GOC:jl, ISBN:0198506732] |
ATPase binding | molecular function | Binding to an ATPase, any enzyme that catalyzes the hydrolysis of ATP. [GOC:ai] |
growth factor receptor binding | molecular function | Binding to a growth factor receptor. [GOC:mah, GOC:vw] |
Located In
This protein is located in 16 target(s):
Target | Category | Definition |
Golgi membrane | cellular component | The lipid bilayer surrounding any of the compartments of the Golgi apparatus. [GOC:mah] |
lysosomal membrane | cellular component | The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm. [GOC:ai] |
early endosome | cellular component | A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways. [GOC:mah, NIF_Subcellular:nlx_subcell_20090701, PMID:19696797] |
endoplasmic reticulum | cellular component | The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached). [ISBN:0198506732] |
endoplasmic reticulum membrane | cellular component | The lipid bilayer surrounding the endoplasmic reticulum. [GOC:mah] |
Golgi apparatus | cellular component | A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways. [ISBN:0198506732] |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
focal adhesion | cellular component | A cell-substrate junction that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. In insects focal adhesion has also been referred to as hemi-adherens junction (HAJ). [GOC:aruk, GOC:bc, ISBN:0124325653, ISBN:0815316208, PMID:10419689, PMID:12191915, PMID:15246682, PMID:1643657, PMID:16805308, PMID:19197329, PMID:23033047, PMID:26923917, PMID:28796323, PMID:8314002] |
synaptic vesicle | cellular component | A secretory organelle, typically 50 nm in diameter, of presynaptic nerve terminals; accumulates in high concentrations of neurotransmitters and secretes these into the synaptic cleft by fusion with the 'active zone' of the presynaptic plasma membrane. [PMID:10099709, PMID:12563290] |
endosome membrane | cellular component | The lipid bilayer surrounding an endosome. [GOC:mah] |
membrane | cellular component | A lipid bilayer along with all the proteins and protein complexes embedded in it and attached to it. [GOC:dos, GOC:mah, ISBN:0815316194] |
azurophil granule membrane | cellular component | The lipid bilayer surrounding an azurophil granule, a primary lysosomal granule found in neutrophil granulocytes that contains a wide range of hydrolytic enzymes and is released into the extracellular fluid. [GOC:bf, PMID:17152095] |
sarcolemma | cellular component | The outer membrane of a muscle cell, consisting of the plasma membrane, a covering basement membrane (about 100 nm thick and sometimes common to more than one fiber), and the associated loose network of collagen fibers. [ISBN:0198506732] |
melanosome | cellular component | A tissue-specific, membrane-bounded cytoplasmic organelle within which melanin pigments are synthesized and stored. Melanosomes are synthesized in melanocyte cells. [GOC:jl, PMID:11584301] |
presynaptic membrane | cellular component | A specialized area of membrane of the axon terminal that faces the plasma membrane of the neuron or muscle fiber with which the axon terminal establishes a synaptic junction; many synaptic junctions exhibit structural presynaptic characteristics, such as conical, electron-dense internal protrusions, that distinguish it from the remainder of the axon plasma membrane. [GOC:jl, ISBN:0815316194] |
extracellular exosome | cellular component | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. [GOC:BHF, GOC:mah, GOC:vesicles, PMID:15908444, PMID:17641064, PMID:19442504, PMID:19498381, PMID:22418571, PMID:24009894] |
Active In
This protein is active in 1 target(s):
Target | Category | Definition |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
Part Of
This protein is part of 1 target(s):
Target | Category | Definition |
gamma-secretase complex | cellular component | A protein complex that has aspartic-type endopeptidase activity and contains a presenilin catalytic subunit (either PSEN1 or PSEN2), an APH1 subunit (multiple genes and splice variants exist), nicastrin (NCT), and presenilin enhancer (aka PEN-2 or Psenen), as the core complex. Variants of the complex with different subunit compositions differ in localization and specific substrates. Additionally, variants of the complex exist that contain a additional regulatory subunit as well as the four core subunits; known regulatory subunits include gamma-secretase-activating protein (aka gSAP), TMP1 (aka TMED10), and CD147 antigen (aka basigin). Gamma-secretase cleaves type I transmembrane protein substrates, including the cell surface receptor Notch and the amyloid-beta precursor protein. [GOC:krc, PMID:15286082, PMID:15890777, PMID:17047368, PMID:22122073, PMID:25565961, PMID:28320827, PMID:32616437] |
Involved In
This protein is involved in 25 target(s):
Target | Category | Definition |
myeloid cell homeostasis | biological process | The process of regulating the proliferation and elimination of myeloid cells such that the total number of myeloid cells within a whole or part of an organism is stable over time in the absence of an outside stimulus. [CL:0000763, GOC:add] |
proteolysis | biological process | The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds. [GOC:bf, GOC:mah] |
membrane protein ectodomain proteolysis | biological process | The proteolytic cleavage of transmembrane proteins and release of their ectodomain (extracellular domain). [GOC:jl, http://www.copewithcytokines.de/] |
dopamine receptor signaling pathway | biological process | The series of molecular signals generated as a consequence of a dopamine receptor binding to one of its physiological ligands. [GOC:mah, PMID:21711983] |
glutamate receptor signaling pathway | biological process | The series of molecular signals initiated by the binding of glutamate to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. [GOC:mah, GOC:signaling, PMID:9131252] |
Notch signaling pathway | biological process | The series of molecular signals initiated by an extracellular ligand binding to the receptor Notch on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. [GOC:go_curators, GOC:signaling] |
Notch receptor processing | biological process | The series of successive proteolytic cleavages of the Notch protein, which result in an active form of the receptor. [PMID:12651094, PMID:14986688] |
learning or memory | biological process | The acquisition and processing of information and/or the storage and retrieval of this information over time. [GOC:jid, PMID:8938125] |
positive regulation of endopeptidase activity | biological process | Any process that increases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins. [GOC:dph, GOC:tb] |
protein processing | biological process | Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a protein. Protein maturation is the process leading to the attainment of the full functional capacity of a protein. [GOC:curators, GOC:jl, GOC:jsg] |
cerebellum development | biological process | The process whose specific outcome is the progression of the cerebellum over time, from its formation to the mature structure. The cerebellum is the portion of the brain in the back of the head between the cerebrum and the pons. In mice, the cerebellum controls balance for walking and standing, modulates the force and range of movement and is involved in the learning of motor skills. [GO_REF:0000021, GOC:cls, GOC:dgh, GOC:dph, GOC:jid, ISBN:0838580343] |
central nervous system myelination | biological process | The process in which neuronal axons and dendrites become coated with a segmented lipid-rich sheath (myelin) to enable faster and more energetically efficient conduction of electrical impulses. The sheath is formed by the cell membranes of oligodendrocytes in the central nervous system. Adjacent myelin segments are separated by a non-myelinated stretch of axon called a node of Ranvier. [GO_REF:0000021, GOC:cls, GOC:dgh, GOC:dph, GOC:jid] |
adult behavior | biological process | Behavior in a fully developed and mature organism. [GOC:mah, ISBN:0877797099] |
membrane protein intracellular domain proteolysis | biological process | The proteolytic cleavage of a transmembrane protein leading to the release of an intracellular domain. [PMID:12808018] |
amyloid-beta formation | biological process | The generation of amyloid-beta by cleavage of the amyloid precursor protein (APP). [GOC:mah] |
T cell proliferation | biological process | The expansion of a T cell population by cell division. Follows T cell activation. [GOC:jl] |
amyloid precursor protein metabolic process | biological process | The chemical reactions and pathways involving amyloid precursor protein (APP), the precursor of amyloid-beta, a glycoprotein associated with Alzheimer's disease. [GOC:go_curators] |
amyloid precursor protein biosynthetic process | biological process | The chemical reactions and pathways resulting in the formation of amyloid precursor protein (APP), the precursor of amyloid-beta, a glycoprotein associated with Alzheimer's disease. [GOC:go_curators] |
positive regulation of amyloid precursor protein biosynthetic process | biological process | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of amyloid precursor protein (APP), the precursor of amyloid-beta. [GOC:go_curators] |
amyloid precursor protein catabolic process | biological process | The chemical reactions and pathways resulting in the breakdown of amyloid precursor protein (APP), the precursor of amyloid-beta, a glycoprotein associated with Alzheimer's disease. [GOC:go_curators] |
epithelial cell proliferation | biological process | The multiplication or reproduction of epithelial cells, resulting in the expansion of a cell population. Epithelial cells make up the epithelium, the covering of internal and external surfaces of the body, including the lining of vessels and other small cavities. It consists of cells joined by small amounts of cementing substances. [ISBN:0721662544] |
neuron apoptotic process | biological process | Any apoptotic process in a neuron, the basic cellular unit of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the nervous system. [CL:0000540, GOC:mtg_apoptosis] |
cellular response to calcium ion | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus. [GOC:mah] |
regulation of long-term synaptic potentiation | biological process | Any process that modulates the frequency, rate or extent of long-term synaptic potentiation. [GOC:BHF, GOC:TermGenie] |
short-term synaptic potentiation | biological process | The process by which synaptic transmission, induced by the arrival of a spike (action potential) at a synapse, acts to increase the amount of neurotransmitter released in response to the arrival of subsequent spikes. This effect is seen when a train of closely space spikes arrives at a synapse with a low initial release probability. It occurs in a timeframe of tens to hundreds of milliseconds. [GOC:dos, GOC:sp, ISBN:9780071120005, PMID:11826273, PMID:26738595] |